The prototype of bradykinin-mediated angioedema is HAE, an autosomal-dominant disorder characterized by recurrent angioedema due to decreased levels of functional C1 esterase inhibitor (C1-INH), which requires disease-specific medications (7, 8). This evidence concerns the gene SERPING1 and hereditary angioedema.